SELLAS Life Sciences (SLS) Free Cash Flow (2019 - 2024)
Historic Free Cash Flow for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to -$7.8 million.
- SELLAS Life Sciences' Free Cash Flow fell 1326.18% to -$7.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$33.1 million, marking a year-over-year decrease of 421.27%. This contributed to the annual value of -$35.4 million for FY2024, which is 1270.93% down from last year.
- As of Q3 2024, SELLAS Life Sciences' Free Cash Flow stood at -$7.8 million, which was down 1326.18% from -$9.7 million recorded in Q2 2024.
- SELLAS Life Sciences' 5-year Free Cash Flow high stood at $3.4 million for Q4 2020, and its period low was -$12.1 million during Q1 2023.
- Over the past 5 years, SELLAS Life Sciences' median Free Cash Flow value was -$5.9 million (recorded in 2021), while the average stood at -$6.3 million.
- As far as peak fluctuations go, SELLAS Life Sciences' Free Cash Flow plummeted by 24532.71% in 2021, and later skyrocketed by 3037.3% in 2022.
- Over the past 5 years, SELLAS Life Sciences' Free Cash Flow (Quarter) stood at $3.4 million in 2020, then crashed by 245.33% to -$5.0 million in 2021, then fell by 3.54% to -$5.2 million in 2022, then increased by 6.35% to -$4.8 million in 2023, then plummeted by 61.78% to -$7.8 million in 2024.
- Its last three reported values are -$7.8 million in Q3 2024, -$9.7 million for Q2 2024, and -$10.8 million during Q1 2024.